** = Publikationen gelistet in SCI/SSCI/Pubmed
** Prunea, DM; Bachl, E; Herold, L; Kanoun, Schnur, SS; Pätzold, S; Altmanninger-Sock, S; Sommer, GA; Glantschnig, T; Kolesnik, E; Wallner, M; Ablasser, K; Bugger, H; Buschmann, E; Praschk, A; Fruhwald, FM; Schmidt, A; von, Lewinski, D; Toth, GG
Impact of the Timing of Mechanical Circulatory Support on the Outcomes in Myocardial Infarction-Related Cardiogenic Shock: Subanalysis of the PREPARE CS Registry.
J Clin Med. 2024; 13(6): 1552
Doi: 10.3390/jcm13061552
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Herold, L; Toth-Gayor, G; Fruhwald, F; Patzold, S; Altmanninger-Sock, S; Harb, S; Schmidt, A; Buschmann, E; Bugger, H; Ablasser, K; Glantschnig, T; Bisping, E; Stoffel, C; Knopper, S; Weixler, R; Muckenauer, W; Zweiker, R; Gasser, R; Zirlik, A; von Lewinski, D
Influence of OFF-hours admission on outcome of CS-patients at a high-volume cardiology centre
WIEN KLIN WOCHENSCHR. Abstracts der Österreichische Kardiologische Gesellschaft Jahrestagung 2022. 2022; 134(SUPPL 2):190-191.-Österreichische Kardiologische Gesellschaft Jahrestagung 2022; MAI 25-28, 2022; Salzburg, AUSTRIA.
[Poster]
Web of Science
** G Toth, G; Ono, M; Buschmann, E; Wu, X; Edl, D; Onuma, Y; Serruys, PW; Wijns, W
Usability of Fantom Encore® scaffold in non-complex bifurcations-Analysis in bench models.
CATHETER CARDIO INTE. 2021; 22(4):
Doi: 10.1002/ccd.29510
Web of Science
PubMed
FullText
FullText_MUG
** Bärnthaler, T; Mahla, E; Toth, GG; Schuligoi, R; Prüller, F; Buschmann, E; Heinemann, A
Supplemental Fibrinogen Restores Platelet Inhibitor-Induced Reduction in Thrombus Formation without Altering Platelet Function: An In Vitro Study.
Thromb Haemost. 2020; 120(11):1548-1556
Doi: 10.1055/s-0040-1715445
Web of Science
PubMed
FullText
FullText_MUG
** Picard, F; Panagiotidou, P; Wolf-Pütz, A; Buschmann, I; Buschmann, E; Steffen, M; Peters, H; Klein, RM
Individual shear rate therapy (ISRT)-further development of external counterpulsation for decreasing blood pressure in patients with symptomatic coronary artery disease (CAD).
Hypertens Res. 2020; 43(3):186-196
Doi: 10.1038/s41440-019-0380-x
Web of Science
PubMed
FullText
FullText_MUG
** Gollmer, J; Verheyen, N; Ablasser, K; Zirngast, B; Marte, W; Buschmann, E; Machler, H; Zirlik, A; Schmidt, A
Procedural Results and Characteristics of Patients after interventional Tricuspid Calve Therapy with the MitraClip Device in severe Tricuspid Valve Regurgitation.
WIEN KLIN WOCHENSCHR. Abstracts 51. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin. 2020; 132(SUPPL 2):84-84.-51. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 24-26, 2020; Salzburg, AUSTRIA.
[Oral Communication]
Web of Science
** Buschmann, EE; Hillmeister, P; Bondke Persson, A; Liebeskind, DS; Schlich, L; Kamenzky, R; Busjahn, A; Buschmann, IR; Bramlage, P; Hetzel, A; Reinhard, M
Short-term external counterpulsation augments cerebral blood flow and tissue oxygenation in chronic cerebrovascular occlusive disease.
EUR J NEUROL. 2018; 25(11): 1326-1332.
Doi: 10.1111/ene.13725
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Buschmann, EE; Lee, EJ; Jacobi, D; Woischnig, AK; Ulusans, S; Schumacher, M; Smith, KH; Pagonas, N; Bramlage, P; Klisch, J; Hillmeister, P; Buschmann, IR
Induction of extracranial arteriogenesis by an arteriovenous fistula in a pig model.
ATHEROSCLEROSIS. 2018; 272(11): 87-93.
Doi: 10.1016/j.atherosclerosis.2018.03.008
Web of Science
PubMed
FullText
FullText_MUG
** Buschmann, EE; Li, L; Brix, M; Zietzer, A; Hillmeister, P; Busjahn, A; Bramlage, P; Buschmann, I
A novel computer-aided diagnostic approach for detecting peripheral arterial disease in patients with diabetes.
PLOS ONE. 2018; 13(6): e0199374-e0199374.
Doi: 10.1371/journal.pone.0199374
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Gatzke, N; Güc, N; Hillmeister, P; Dülsner, A; Le Noble, F; Buschmann, EE; Ingwersen, M; Bramlage, P; Buschmann, IR
Cardiovascular drugs attenuated myocardial resistance against ischaemia-induced and reperfusion-induced injury in a rat model of repetitive occlusion.
Open Heart. 2018; 5(2): e000889-e000889.
Doi: 10.1136/openhrt-2018-000889
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Picard, F; Panagiotidou, P; Wolf-Pütz, A; Buschmann, I; Buschmann, E; Steffen, M; Klein, RM
Usefulness of Individual Shear Rate Therapy, New Treatment Option for Patients With Symptomatic Coronary Artery Disease.
Am J Cardiol. 2018; 121(4): 416-422.
Doi: 10.1016/j.amjcard.2017.11.004
Web of Science
PubMed
FullText
FullText_MUG
** Brix, M; Buschmann, EE; Zietzer, A; Jaurigue, JA; Li, L; Jungk, C; Buschmann, I; Janke, D; Hillmeister, P
Long-term individual shear rate therapy counterpulsation enhances plasma nitrite release in patients with PAD.
Vasa. 2017; 46(1): 37-45.
Doi: 10.1024/0301-1526/a000600
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Zietzer, A; Buschmann, EE; Janke, D; Li, L; Brix, M; Meyborg, H; Stawowy, P; Jungk, C; Buschmann, I; Hillmeister, P
Acute physical exercise and long-term individual shear rate therapy increase telomerase activity in human peripheral blood mononuclear cells.
Acta Physiol (Oxf). 2017; 220(2): 251-262.
Doi: 10.1111/apha.12820
Web of Science
PubMed
FullText
FullText_MUG
** Hillmeister, P; Buschmann, E; Persson, PB; Bondke Persson, A
Exercise for healthy flow.
Acta Physiol (Oxf). 2017; 219(1): 3-8.
Doi: 10.1111/apha.12831
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Buschmann, EE; Brix, M; Li, L; Doreen, J; Zietzer, A; Li, M; Buschmann, I; Hillmeister, P
Adaptation of external counterpulsation based on individual shear rate therapy improves endothelial function and claudication distance in peripheral artery disease.
Vasa. 2016; 45(4): 317-324.
Doi: 10.1024/0301-1526/a000544
Web of Science
PubMed
FullText
FullText_MUG
** Langhoff, R; Behne, A; Buschmann, EE
Promising role of drug-coated balloons in the tibial vessels?
J Cardiovasc Surg (Torino). 2016;
[OPEN ACCESS]
PubMed
** Pagonas, N; Gross, CM; Li, M; Bondke, A; Klauss, V; Buschmann, EE
Influence of epicardial stenosis severity and central venous pressure on the index of microcirculatory resistance in a follow-up study.
EuroIntervention. 2014; 9(9): 1063-1068.
Doi: 10.4244/EIJV9I9A180
Web of Science
PubMed
FullText
FullText_MUG
** Bondke Persson, A; Buschmann, EE; Lindhorst, R; Troidl, K; Langhoff, R; Schulte, KL; Buschmann, I
Therapeutic arteriogenesis in peripheral arterial disease: combining intervention and passive training.
Vasa. 2011; 40(3): 177-187.
Doi: 10.1024/0301-1526/a000092
Web of Science
PubMed
FullText
FullText_MUG
** Jungehuelsing, GJ; Liman, TG; Brunecker, P; Ebel, A; Endres, M; Buschmann, I; Pagonas, N; Buschmann, EE; Arteriogenesis Network; Center for Stroke Research Berlin
Does external counterpulsation augment mean cerebral blood flow in the healthy brain? Effects of external counterpulsation on middle cerebral artery flow velocity and cerebrovascular regulatory response in healthy subjects.
Cerebrovasc Dis. 2010; 30(6): 612-617.
Doi: 10.1159/000319891
Web of Science
PubMed
FullText
FullText_MUG
** Pagonas, N; Utz, W; Schulz-Menger, J; Busjahn, A; Monti, J; Thierfelder, L; Dietz, R; Klauss, V; Gross, M; Buschmann, IR; Buschmann, EE; Arteriogenesis Network (Art.Net.)
Assessment of the effect of external counterpulsation on myocardial adaptive arteriogenesis by invasive functional measurements--design of the arteriogenesis network trial 2.
Int J Cardiol. 2010; 145(3): 432-437.
Doi: 10.1016/j.ijcard.2009.05.050
Web of Science
PubMed
FullText
FullText_MUG
** von Knobelsdorff-Brenkenhoff, F; Buschmann, EE; Pilz, B; Schulz-Menger, J
Persistent Cabrol shunt causing severe right heart failure.
Ann Thorac Surg. 2010; 90(1): 312-312.
Doi: 10.1016/j.athoracsur.2009.10.028
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
** Buschmann, EE; Utz, W; Pagonas, N; Schulz-Menger, J; Busjahn, A; Monti, J; Maerz, W; le Noble, F; Thierfelder, L; Dietz, R; Klauss, V; Gross, M; Buschmann, IR; Arteriogenesis Network (Art. Net.)
Improvement of fractional flow reserve and collateral flow by treatment with external counterpulsation (Art.Net.-2 Trial).
Eur J Clin Invest. 2009; 39(10): 866-875.
Doi: 10.1111/j.1365-2362.2009.02192.x
Web of Science
PubMed
FullText
FullText_MUG
** von Knobelsdorff-Brenkenhoff, F; Rudolph, A; Wassmuth, R; Bohl, S; Buschmann, EE; Abdel-Aty, H; Dietz, R; Schulz-Menger, J
Feasibility of cardiovascular magnetic resonance to assess the orifice area of aortic bioprostheses.
Circ Cardiovasc Imaging. 2009; 2(5): 397-404.
Doi: 10.1161/CIRCIMAGING.108.840967
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Bondke, A; Buschmann, IR; Bode, C; Buschmann, EE
Inducing collaterals in due time. Arteriogenesis as a preventive principle].
Hamostaseologie. 2007; 27(5): 363-372.
Doi: 10.1055/s-0037-1617011
PubMed
FullText
FullText_MUG
** van Royen, N; Schirmer, SH; Atasever, B; Behrens, CY; Ubbink, D; Buschmann, EE; Voskuil, M; Bot, P; Hoefer, I; Schlingemann, RO; Biemond, BJ; Tijssen, JG; Bode, C; Schaper, W; Oskam, J; Legemate, DA; Piek, JJ; Buschmann, I
START Trial: a pilot study on STimulation of ARTeriogenesis using subcutaneous application of granulocyte-macrophage colony-stimulating factor as a new treatment for peripheral vascular disease.
Circulation. 2005; 112(7): 1040-1046.
Doi: 10.1161/CIRCULATIONAHA.104.529552
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** van Royen, N; Piek, JJ; Legemate, DA; Schaper, W; Oskam, J; Atasever, B; Voskuil, M; Ubbink, D; Schirmer, SH; Buschmann, I; Bode, C; Buschmann, EE
Design of the START-trial: STimulation of ARTeriogenesis using subcutaneous application of GM-CSF as a new treatment for peripheral vascular disease. A randomized, double-blind, placebo-controlled trial.
Vasc Med. 2003; 8(3):191-196
Doi: 10.1191/1358863x03vm496oa
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Buschmann, I; Katzer, E; Bode, C
Arteriogenesis - is this terminology necessary?
Basic Res Cardiol. 2003; 98(1):1-5
Doi: 10.1007/s00395-003-0388-9
Web of Science
PubMed
FullText
FullText_MUG
** Buschmann, IR; Hoefer, IE; van Royen, N; Katzer, E; Braun-Dulleaus, R; Heil, M; Kostin, S; Bode, C; Schaper, W
GM-CSF: a strong arteriogenic factor acting by amplification of monocyte function.
Atherosclerosis. 2001; 159(2):343-356
Doi: 10.1016/S0021-9150(01)00637-2
Web of Science
PubMed
FullText
FullText_MUG
** Katzer, EE; Renner, O; Buschmann, IR; Heil, M; Deindl, E; Hofer, IE; Klein, W; Clauss, M; Schaper, W
Chemokine expression profile of human monocytes after stimulation with LPS: New insight by gene-arrays
J AMER COLL CARDIOL 2000 35: 297A-297A.
Web of Science
** Brinckmann, J; Açil, Y; Feshchenko, S; Katzer, E; Brenner, R; Kulozik, A; Kügler, S
Ehlers-Danlos syndrome type VI: lysyl hydroxylase deficiency due to a novel point mutation (W612C).
Arch Dermatol Res. 1998; 290(4):181-186
Doi: 10.1007/s004030050287
Web of Science
PubMed
FullText
FullText_MUG